The Advisory Committee on Immunization Practices, a group of medical experts that advises the CDC, had expected to vote at a meeting Sept. 22 on a plan to give priority to early doses of a COVID-19 vaccine.
The committee may instead wait until a vaccine is authorized before voting on a plan, people familiar with the situation told the Journal. The next committee meeting is scheduled for late October.
The committee said previously that front-line healthcare workers would likely receive priority status when it comes to COVID-19 vaccines. The committee doesn’t have final say in the matter, but it sends recommendations to the CDC which then decides whether to make them policy.
A separate committee, called the National Academies of Sciences, Engineering, and Medicine is also developing an allocation plan for COVID-19 vaccines.
William Schaffner, a liaison to the vaccine advisory committee, told the Journal that the longer it takes to develop a prioritization plan, the more difficult it will be for state health officials to come up with vaccination plans.
Read the full article here.
More articles on pharmacy:
FDA now requiring boxed warning for benzodiazepines
CVS accused of patient steering
HHS general counsel scolds Eli Lilly for halting 340B drug discounts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
